{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:26:34Z","timestamp":1786767994837,"version":"build-2736575974"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bpobgyn.2026.102748","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:36:03Z","timestamp":1782851763000},"page":"102748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Preventing congenital cytomegalovirus infection in transplant recipients; a focus on uterine transplantation"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1642-3011","authenticated-orcid":false,"given":"A.","family":"L'Heveder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Jeffery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Lyall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Nastouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Onanuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Devaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Frise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.P.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Quiroga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bpobgyn.2026.102748_bib1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/aogs.15080","article-title":"A decade of human uterus transplantation","volume":"104","author":"Br\u00e4nnstr\u00f6m","year":"2025","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"10.1016\/j.bpobgyn.2026.102748_bib2","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1111\/1471-0528.17966","article-title":"Congenital cytomegalovirus infection: update on screening, diagnosis and treatment: Scientific impact paper no. 56","volume":"132","author":"Khalil","year":"2025","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"10253","key":"10.1016\/j.bpobgyn.2026.102748_bib3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(20)31868-7","article-title":"Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial","volume":"396","author":"Shahar-Nissan","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bpobgyn.2026.102748_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ajog.2023.07.022","article-title":"The effect of valacyclovir on secondary prevention of congenital cytomegalovirus infection, following primary maternal infection acquired periconceptionally or in the first trimester of pregnancy. An individual patient data meta-analysis","volume":"230","author":"Chatzakis","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2026.102748_bib5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/uog.26136","article-title":"Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta\u2010analysis","volume":"61","author":"D'Antonio","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2026.102748_bib6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/uog.19164","article-title":"Prevention of maternal\u2013fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration","volume":"53","author":"Kagan","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2026.102748_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13653","article-title":"Pregnancy after CMV infection following uterus transplantation: a case report from the Dallas uterus transplant study","volume":"23","author":"Rosenzweig","year":"2021","journal-title":"Transpl Infect Dis"},{"issue":"11","key":"10.1016\/j.bpobgyn.2026.102748_bib8","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s40265-018-0943-1","article-title":"New developments in the management of cytomegalovirus infection after transplantation","volume":"78","author":"Meesing","year":"2018","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.bpobgyn.2026.102748_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12732","article-title":"Burden of cytomegalovirus disease in solid organ transplant recipients: a national matched cohort study in an inpatient setting","volume":"19","author":"Hakimi","year":"2017","journal-title":"Transpl Infect Dis"},{"issue":"7","key":"10.1016\/j.bpobgyn.2026.102748_bib10","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/TP.0000000000005374","article-title":"The fourth international consensus guidelines on the management of cytomegalovirus in solid organ transplantation","volume":"109","author":"Kotton","year":"2025","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.bpobgyn.2026.102748_bib11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40121-022-00746-1","article-title":"New insights on CMV management in solid organ transplant patients: prevention, treatment, and management of resistant\/refractory disease","volume":"12","author":"Kotton","year":"2023","journal-title":"Infect Dis Ther"},{"issue":"9","key":"10.1016\/j.bpobgyn.2026.102748_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13512","article-title":"Cytomegalovirus in solid organ transplant recipients\u2014Guidelines of the American society of transplantation infectious diseases community of practice","volume":"33","author":"Razonable","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bpobgyn.2026.102748_bib13","series-title":"UK guideline on prevention and management of cytomegalovirus (CMV) infection and disease following solid organ transplantation","year":"2022"},{"issue":"8","key":"10.1016\/j.bpobgyn.2026.102748_bib14","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/10898540-000000000-00000","article-title":"New developments in the management of cytomegalovirus infection after solid organ transplantation","volume":"70","author":"Eid","year":"2010","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.bpobgyn.2026.102748_bib15","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","article-title":"The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high\u2010risk kidney transplant recipients","volume":"10","author":"Humar","year":"2010","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.bpobgyn.2026.102748_bib16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/cis993","article-title":"Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study","volume":"56","author":"Manuel","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.bpobgyn.2026.102748_bib17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/tid.12417","article-title":"Effect of long\u2010term prophylaxis in the development of cytomegalovirus\u2010specific t\u2010cell immunity in D+\/R\u2212 solid organ transplant recipients","volume":"17","author":"San-Juan","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bpobgyn.2026.102748_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11963","article-title":"Cytomegalovirus cell-mediated immunity: ready for routine use?","volume":"36","author":"Bestard","year":"2023","journal-title":"Transpl Int"},{"issue":"6","key":"10.1016\/j.bpobgyn.2026.102748_bib19","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.bpobgyn.2026.102748_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13666","article-title":"Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: a multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies","volume":"33","author":"Girmenia","year":"2019","journal-title":"Clin Transplant"},{"issue":"9","key":"10.1016\/j.bpobgyn.2026.102748_bib21","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/j.1600-6143.2007.01910.x","article-title":"Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients","volume":"7","author":"Asberg","year":"2007","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.bpobgyn.2026.102748_bib22","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1600-6143.2009.02617.x","article-title":"Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients","volume":"9","author":"Asberg","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bpobgyn.2026.102748_bib23","series-title":"Maribavir for treating refractory cytomegalovirus infection after transplant. (TA860)","year":"2023"},{"issue":"9","key":"10.1016\/j.bpobgyn.2026.102748_bib24","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1111\/ajt.14347","article-title":"An interventional study using cell-mediated immunity to personalize therapy for cytomegalovirus infection after transplantation","volume":"17","author":"Kumar","year":"2017","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.bpobgyn.2026.102748_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.20736","article-title":"Congenital cytomegalovirus infection burden and epidemiologic risk factors in countries with universal screening: a systematic review and meta-analysis","volume":"4","author":"Ssentongo","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.bpobgyn.2026.102748_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta\u2010analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev Med Virol"},{"issue":"9","key":"10.1016\/j.bpobgyn.2026.102748_bib27","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.09.19140-en","article-title":"Epidemiological impact and disease burden of congenital cytomegalovirus infection in Europe","volume":"14","author":"Ludwig","year":"2009","journal-title":"Euro Surveill"},{"issue":"5","key":"10.1016\/j.bpobgyn.2026.102748_bib28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev Med Virol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2026.102748_bib29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.reprotox.2005.02.002","article-title":"Fetal effects of primary and secondary cytomegalovirus infection in pregnancy","volume":"21","author":"Ornoy","year":"2006","journal-title":"Reprod Toxicol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2026.102748_bib30","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ajog.2020.05.038","article-title":"Timing of primary maternal cytomegalovirus infection and rates of vertical transmission and fetal consequences","volume":"223","author":"Chatzakis","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2026.102748_bib31","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3390\/jcm13072136","article-title":"Is a higher amniotic fluid viral load associated with a greater risk of fetal injury in congenital cytomegalovirus infection\u2014A systematic review and meta-analysis","volume":"13","author":"Gilad","year":"2024","journal-title":"J Clin Med"},{"issue":"13","key":"10.1016\/j.bpobgyn.2026.102748_bib32","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/pd.5757","article-title":"Is it time for routine prenatal serological screening for congenital cytomegalovirus?","volume":"40","author":"Leruez\u2010Ville","year":"2020","journal-title":"Prenat Diagn"},{"issue":"10","key":"10.1016\/j.bpobgyn.2026.102748_bib33","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/INF.0000000000002763","article-title":"Prevention of acquisition of cytomegalovirus infection in pregnancy through hygiene-based behavioral interventions: a systematic review and gap analysis","volume":"39","author":"Barber","year":"2020","journal-title":"Pediatr Infect Dis J"},{"issue":"14","key":"10.1016\/j.bpobgyn.2026.102748_bib34","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMoa1310214","article-title":"A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus","volume":"370","author":"Revello","year":"2014","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.bpobgyn.2026.102748_bib35","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJMoa1913569","article-title":"A trial of hyperimmune globulin to prevent congenital cytomegalovirus infection","volume":"385","author":"Hughes","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.bpobgyn.2026.102748_bib36","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/14787210.2021.1846521","article-title":"Hyperimmunoglobulin therapy for the prevention and treatment of congenital cytomegalovirus: a systematic review and meta-analysis","volume":"19","author":"El-Qushayri","year":"2021","journal-title":"Expert Rev Anti-infect Ther"},{"issue":"9","key":"10.1016\/j.bpobgyn.2026.102748_bib37","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1471-0528.2007.01308.x","article-title":"Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection","volume":"114","author":"Jacquemard","year":"2007","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2026.102748_bib38","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ajog.2016.04.003","article-title":"In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study","volume":"215","author":"Leruez-Ville","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2026.102748_bib39","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157415","article-title":"Amniotic fluid biomarkers predict the severity of congenital cytomegalovirus infection","volume":"132","author":"Vorontsov","year":"2022","journal-title":"J Clin Investig"},{"key":"10.1016\/j.bpobgyn.2026.102748_bib40","article-title":"Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the european congenital infection initiative (ECCI)","volume":"40","author":"Leruez-Ville","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"2","key":"10.1016\/j.bpobgyn.2026.102748_bib41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1399-3062.2005.00089.x","article-title":"Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient","volume":"7","author":"Puliyanda","year":"2005","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"10.1016\/j.bpobgyn.2026.102748_bib42","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/jlts.2000.18703","article-title":"Pregnancy after liver transplantation","volume":"6","author":"Armenti","year":"2000","journal-title":"Liver Transplant"},{"issue":"7","key":"10.1016\/j.bpobgyn.2026.102748_bib43","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/j.1600-6143.2005.00969.x","article-title":"Reproduction and transplantation: report on the AST consensus conference on reproductive issues and transplantation","volume":"5","author":"McKay","year":"2005","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.bpobgyn.2026.102748_bib44","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/1471-0528.15860","article-title":"Rethinking the time interval to embryo transfer after uterus transplantation\u2013DUETS (Dallas UtErus Transplant Study)","volume":"126","author":"Johannesson","year":"2019","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"9968","key":"10.1016\/j.bpobgyn.2026.102748_bib45","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(14)61728-1","article-title":"Livebirth after uterus transplantation","volume":"385","author":"Br\u00e4nnstr\u00f6m","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bpobgyn.2026.102748_bib46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.fertnstert.2014.09.024","article-title":"Uterus transplantation trial: 1-year outcome","volume":"103","author":"Johannesson","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2026.102748_bib47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijid.2022.09.038","article-title":"Recurrent congenital cytomegalovirus infection in a sequential pregnancy with severe sequelae, and a possible association with prophylactic valacyclovir treatment: a case report","volume":"125","author":"Brosh-Nissimov","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.bpobgyn.2026.102748_bib48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/clinids\/20.1.52","article-title":"Congenital cytomegalovirus infection in offspring of liver transplant recipients","volume":"20","author":"Laifer","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.bpobgyn.2026.102748_bib49","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/j.ackd.2020.06.004","article-title":"Pregnancy in kidney transplant recipients","volume":"27","author":"Gonzalez Suarez","year":"2020","journal-title":"Adv Chron Kidney Dis"},{"issue":"4","key":"10.1016\/j.bpobgyn.2026.102748_bib50","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/uog.20353","article-title":"Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta\u2010analysis","volume":"54","author":"Salomon","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2026.102748_bib51","doi-asserted-by":"crossref","DOI":"10.1111\/1471-0528.16821","article-title":"Amniocentesis and chorionic villus sampling: green\u2010top guideline No. 8","volume":"129","author":"Navaratnam","year":"2022","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"9","key":"10.1016\/j.bpobgyn.2026.102748_bib52","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1111\/j.1600-6143.2005.00993.x","article-title":"Successful renal transplantation during pregnancy","volume":"5","author":"Hold","year":"2005","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.bpobgyn.2026.102748_bib53","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2215\/CJN.07020714","article-title":"Randomized trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation","volume":"10","author":"Reischig","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.bpobgyn.2026.102748_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2024.105678","article-title":"Valacyclovir or valganciclovir for cytomegalovirus prophylaxis: a randomized controlled trial in adult and pediatric kidney transplant recipients","volume":"172","author":"Verghese","year":"2024","journal-title":"J Clin Virol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2026.102748_bib55","article-title":"Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients","author":"Vernooij","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.bpobgyn.2026.102748_bib56","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1186\/s12879-018-3493-y","article-title":"Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial","volume":"18","author":"Reischig","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.bpobgyn.2026.102748_bib57","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/00007890-199903150-00021","article-title":"Absence of teratogenicity of oral ganciclovir used during early pregnancy in a liver transplant recipient","volume":"67","author":"Pescovitz","year":"1999","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.bpobgyn.2026.102748_bib58","first-page":"1353","article-title":"Renal transplantation one week after conception","volume":"60","author":"Miller","year":"1995","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.bpobgyn.2026.102748_bib59","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/jac\/dkad087","article-title":"Assessing the risk of adverse pregnancy outcomes and birth defects reporting in women exposed to ganciclovir or valganciclovir during pregnancy: a pharmacovigilance study","volume":"78","author":"Contejean","year":"2023","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.bpobgyn.2026.102748_bib60","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/infdis\/jiaf619","article-title":"Maternal-fetal letermovir exposure in vivo and physiologically based pharmacokinetic modeling: a rationale for congenital cytomegalovirus therapy","volume":"233","author":"Faure Bardon","year":"2026","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bpobgyn.2026.102748_bib63","unstructured":"Toll-Free U. Transplant pregnancy registry international."},{"issue":"10","key":"10.1016\/j.bpobgyn.2026.102748_bib64","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/01.tp.0000263357.44975.d0","article-title":"Pregnancy after organ transplantation: a report from the UK transplant pregnancy registry","volume":"83","author":"Sibanda","year":"2007","journal-title":"Transplantation"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693426000489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693426000489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T03:30:08Z","timestamp":1786764608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693426000489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":62,"alternative-id":["S1521693426000489"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2026.102748","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventing congenital cytomegalovirus infection in transplant recipients; a focus on uterine transplantation","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2026.102748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102748"}}